Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin—a novel tumor checkpoint controller targeting microtubules.
| Autor: | Burgenske, Danielle M, Talele, Surabhi, Pokorny, Jenny L, Mladek, Ann C, Bakken, Katrina K, Carlson, Brett L, Schroeder, Mark A, He, Lihong, Hu, Zeng, Gampa, Gautham, Kosel, Matthew L, Decker, Paul A, Kitange, Gaspar J, Schmitt-Hoffmann, Anne, Bachmann, Felix, Vaubel, Rachael A, Eckel-Passow, Jeanette E, Giannini, Caterina, McSheehy, Paul, Lane, Heidi A |
|---|---|
| Zdroj: | Neuro-Oncology; Mar2022, Vol. 24 Issue 3, p384-395, 12p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|